Skip to main content.

ACO

 

ACO Name and Location

Summa Accountable Care Organization
Previous Names: N/A
1077 Gorge Blvd.
Akron, Ohio 44310

ACO Primary Contact

Contact Name: Laura McCafferty
Contact Phone: 330-996-8533
Contact Email Address: mccaffertyl@summahealth.org

Organizational Information

ACO Participants:

ACO Participants ACO Participant in Joint Venture (Enter Y or N)
Austin Primary Care, LLC N
Brian R. Cain, M.D. And Associates
N
B.S. Bonyo D.O. & Associates, Inc.
N
Diana Brewster
N
Grenville Machado, MD, Inc.
N
Hartville Internal Medicine PA
N
Julie Reeves, MD, Inc.
N
Kreptowski Family Practice, LLC
N
Manor Management Co Inc.
N
Ohio Family Practice Centers, Inc.
N
PAX Medical Associates Inc. N
South Court Family Physicians, Inc.
N
Stark County Medical Group Inc. N
Summa Physicians, Inc.
N
Total Lifetime Care Medical Affiliates, Inc.  
N
Waleed F Nemer MD, Inc.
N

ACO Governing Body:

Members Member's Voting Power Membership Type ACO Participant Legal Business Name and D/B/A, if applicable
Last Name First Name Title/Position
Bachtel Jeffrey MD; Voting Member 1 ACO Participant Representative Summa Physicians, Inc.
Bhalla Vivek MD; Voting Member 1 ACO Participant Representative Summa Physicians, Inc.
Coleman Paul MD; Voting Member 1 ACO Participant Representative Summa Physicians, Inc.
Cook Gary Voting Member 1 Medicare Beneficiary Representative N/A
Cook J. Christian DO; Chairman; Voting Member 1 ACO Participant Representative Austin Primary Care, LLC 
Deveny T. Clifford MD; Voting Member 1 Other - Parent Organization (Summa Health) Representative  Summa Health System
Epling William Ex-Officio (President) 0 Other - Ex-Officio (President) N/A
Hollaway Stacey MD; Voting Member 1 ACO Participant Representative Stark County Medical Group
Hostettler Mark MD; Voting Member 1 ACO Participant Representative Manor Management Co. Inc dba Internal Medicine Phys
Hubbard Dawn MD; Voting Member 1 ACO Participant Representative Summa Physicians, Inc.
Mahesh Sameer MD; Voting Member 1 ACO Participant Representative Summa Physicians, Inc.
Schiaffino Maria Alejandra   MD; Voting Member 1 ACO Participant Representative Summa Physicians, Inc.
Soltis Melissa MD; Voting Member 1 ACO Participant Representative Summa Physicians, Inc.

Key ACO Clinical and Administrative Leadership:

ACO Executive:        William Epling
Medical Director: Dawn Hubbard, MD          
Compliance Officer: Beverly Brouse             
Quality Assurance/Improvement Officer:  Kathy Blake

Associated Committees and Committee Leadership:

Committee Name Committee Leader Name and Position
Clinical Performance:         Dawn Hubbard, MD; Chair 
Finance: Denise Knight; Chair   

Types of ACO Participants, or Combinations of Participants, That Formed the ACO:

  • Partnerships or joint venture arrangements between hospitals and ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses:

Third Agreement Period

  • Performance Year 2020, $5,652,023

Second Agreement Period

  • Performance Year 2019, $3,936,201
  • Performance Year 2018, $4,531,433
  • Performance Year 2017, $0
  • Performance Year 2016, $0

First Agreement Period

  • Performance Year 2015, $3,060,189
  • Performance Year 2014, $4,456,811
  • Performance Year 2013, $5,780,129

Note: Our ACO participated in multiple performance years during Calendar Year 2019. Shared savings/losses amount reported for Performance Year 2019 therefore represents net shared savings or losses across all performance years in 2019 and is shown under all agreement periods in which the ACO operated during Calendar Year 2019

Shared Savings Distribution

Third Agreement Period

  • Performance year 2020
    • Proportion invested in infrastructure: 20%
    • Proportion invested in redesigned care processes/resources: 20%
    • Proportion of distribution to ACO participants: 60%

Second Agreement Period

  • Performance year 2019
    • Proportion invested in infrastructure: 12.5%
    • Proportion invested in redesigned care processes/resources: 12.5%
    • Proportion of distribution to ACO participants: 75%
  • Performance Year 2018
    • Proportion invested in infrastructure: 23.5%
    • Proportion invested in redesigned care processes / resources: 23.5%
    • Proportion of distribution to ACO participants: 53%
  • Performance Year 2017
    • Proportion invested in infrastructure: N/A
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A
  • Performance Year 2016
    • Proportion invested in infrastructure: N/A
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A

First Agreement Period

  • Performance Year 2015
    • Proportion invested in infrastructure: 18.5%
    • Proportion invested in redesigned care processes/resources: 18.5%
    • Proportion of distribution to ACO participants: 63%
  • Performance Year 2014
    • Proportion invested in infrastructure: 17.5%
    • Proportion invested in redesigned care processes/resources: 17.5%
    • Proportion of distribution to ACO participants: 65%
  • Performance Year 2013
    • Proportion invested in infrastructure: 16%
    • Proportion invested in redesigned care processes/resources: 16%
    • Proportion of distribution to ACO participants: 68%

Note: Our ACO participated in multiple performance years during Calendar Year 2019. Distribution of shared savings reported for Performance Year 2019 therefore represents the distribution of the net shared savings across all performance years in 2019 and is shown under all agreement periods in which the ACO operated during Calendar Year 2019.

Quality Performance Results 

2021 Quality Performance Results:

Measure# Measure Name Rate ACO Mean
001 Diabetes: Hemoglobin A1c (HbA1c) Poor Control 9.42 12.46
134 Preventative Care and Screening: Screening for Depression and Follow-up Plan 84.12 74.38
236 Controlling High Blood Pressure 82.71 74.87
318 Falls: Screening for Future Fall Risk 94.44 87.03
110 Preventative Care and Screening: Influenza Immunization 84.55 80.52
226 Preventative Care and Screening: Tobacco Use: Screening and Cessation Intervention 82.14 80.97
113 Colorectal Cancer Screening 75.36 73.63
112  Breast Cancer Screening 73.05 75.11
438  Statin Therapy for the Prevention and Treatment of Cardiovascular Disease 84.19 84.24
479 Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Groups [Risk Standardized, All Condition Readmission]* 0.1592 0.1540
MCC1 All-Cause Unplanned Admission for Patients with Multiple Chronic Conditions 37.26 33.99
CAHPS-1 Getting Timely Care, Appointments, and Information 85.23 84.67
CAHPS-2 How Well Providers Communicate 94.77 9.56 
CAHPS-3 Patient's Rating of Provider 92.78 92.19
CAHPS-4 Access to Specialists 77.80 78.80
CAHPS-5 Health Promotion and Education 64.24 61.61
CAHPS-6 Shared Decision Making 60.96 60.89
CAHPS-7 Health Status and Functional Status 73.28 71.78
CAHPS-8 Care Coordination 86.49 85.66
CAHPS-9 Courteous and Helpful Office Staff 93.10 91.88
CAHPS-11 Stewardship of Patient Resources 23.39 24.71

Please note, the Quality ID #: 370 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size.

For Previous Years’ Financial and Quality Performance Results, Please Visit data.cms.gov

Payment Rule Waivers

  • Skilled Nursing Facility (SNF) 3-Day Rule Waiver:
    o Our ACO uses the SNF 3-Day Rule Waiver, pursuant to 42 CFR § 425.612

Fraud and Abuse Waivers

  • ACO Pre-Participation Waiver: 

   N/A – ACO does not utilize the Pre-Participation Waiver

  • ACO Participation Waiver: 

The following information describes each arrangement for which our ACO seeks protection under the ACO Participation Waiver, including any material amendment or modification to a disclosed arrangement.  

Parties: ACO, ACO participants and other ACO providers/suppliers affiliated with ACO
Date: As of July 1, 2019, as amended February 25, 2021
Description
Care Provision Arrangements: 

Under the Care Provision Arrangements, ACO employs and oversees the use of physicians, specialists, process improvement staff, a tightly aligned post-acute care network, and health care personnel with expertise in integrated care management and care transformation processes to assist ACO participants and other ACO providers/suppliers affiliated with ACO, with:

• coordinating and providing primary and specialty care for high-risk, vulnerable MSSP beneficiary populations;

• managing medication adherence and reconciliation

• appropriately managing care transitions; and

• transforming primary care processes.


Parties: ACO, ACO participants, ACO providers/suppliers, or other providers and suppliers affiliated with ACO
Date: As of July 1, 2019, as amended November 21, 2019
Description
Health IT Arrangements:

Under the Health IT Arrangements, ACO (or, Summa Health or its subsidiary, Summa Health Network, on ACO’s behalf) purchases or contracts for the provision of multiple health Information technology resources, including electronic health record (“EHR”), population health management technology, data analytics systems and data extraction and aggregation tools to facilitate the following benefits for ACO participants, ACO providers/suppliers, or other providers and suppliers affiliated with ACO: 

Access to electronic medical records by and among providers in different care settings; 

Analytics to support referral management among MSSP beneficiaries’ health care providers;

Provision of gap reporting, patient summaries, risk stratification, and enhanced registry services; and 

Support for the coordination of care and population health management of MSSP beneficiaries.


Parties: ACO participants and/or ACO providers’/suppliers 
Date: As of July 1, 2019
Description
Infrastructure & Care Redesign Arrangement:

Under the Infrastructure & Care Redesign Arrangement, ACO assesses an annual “administrative fee” against the ACO participants’ and/or ACO providers’/suppliers’ SummaCare Medicare Advantage and Medicare fee-for-service reimbursement in order to support ACO operations and infrastructure needs. 


Parties: ACO, ACO participants and other ACO providers/suppliers affiliated with ACO
Date: As of July 1, 2019
Description
Care Relationship Arrangements: 

Under the Care Relationship Arrangements, ACO engages in activities that will serve to coordinate care for its beneficiaries with ACO participants and with other providers and suppliers, including but not limited to: the distribution of informational brochures, emails, or other materials about ACO participants and ACO providers/suppliers to patients transitioning from acute to post-acute care facilities, to patients seeking information about available treating providers and suppliers, or to other providers and suppliers that may refer patients to ACO participants. 

 
[{"RootId":"ba198066-3078-4dcd-8e69-28251bebb940","RootUrl":"/glossary/"}]

Options to Request an Appointment

If your situation is an emergency, call 911.